| August 2022 RCJ "Use of a Viral Filter to Reduce Exposure to Exhaled Aerosol Does Not Affect Methacholine Dose Delivery During Bronchoprovocation Testing" |
| Beyond the Blue Bloater: Phenotypical Considerations in COPD |
| Cardiopulmonary Exercise Testing and the Evaluation of the Upper Airway Architecture |
| Cardiopulmonary Exercise Testing: Protocols and the Normal Physiologic Responses |
| Diagnostic Bronchoscopy |
| Diffusing Capacity: 2017 ATS/ERS Standards Implementation in the PF Lab |
| FeNO-an airway biomarker: The what and why of Fractional Exhaled Nitric Oxide |
| Indirect Bronchoprovocation, Better than a Methacholine Challenge? |
| Pulmonary Function Technology Recredentialing Package |
| Pulmonary Function Testing- Advanced Concepts |
| Pulmonary Function Testing- Pediatrics |
| Pulmonary Function Testing-Spirometry |
| The New/Updated ATS-ERS PFT Standards; How do they effect you when testing? |
| Therapeutic Bronchoscopy |
| Tickling or Irritating the Airways- Methacholine Challenge Testing |